KAZANO - 64764-335-60 - (alogliptin and metformin hydrochloride)

Alphabetical Index


Drug Information of KAZANO

Product NDC: 64764-335
Proprietary Name: KAZANO
Non Proprietary Name: alogliptin and metformin hydrochloride
Active Ingredient(s): 12.5; 500    mg/1; mg/1 & nbsp;   alogliptin and metformin hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of KAZANO

Product NDC: 64764-335
Labeler Name: Takeda Pharmaceuticals America, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA203414
Marketing Category: NDA
Start Marketing Date: 20130125

Package Information of KAZANO

Package NDC: 64764-335-60
Package Description: 60 TABLET, FILM COATED in 1 BOTTLE (64764-335-60)

NDC Information of KAZANO

NDC Code 64764-335-60
Proprietary Name KAZANO
Package Description 60 TABLET, FILM COATED in 1 BOTTLE (64764-335-60)
Product NDC 64764-335
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name alogliptin and metformin hydrochloride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20130125
Marketing Category Name NDA
Labeler Name Takeda Pharmaceuticals America, Inc.
Substance Name ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
Strength Number 12.5; 500
Strength Unit mg/1; mg/1
Pharmaceutical Classes Biguanide [EPC],Biguanides [Chemical/Ingredient]

Complete Information of KAZANO


General Information